|
NDUFA13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.032200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.663240E-01 |
| Normal-vs-Stage2 |
7.892600E-01 |
| Normal-vs-Stage3 |
1.94014999999048E-05 |
| Normal-vs-Stage4 |
6.640700E-03 |
| Stage1-vs-Stage2 |
3.623400E-01 |
| Stage1-vs-Stage3 |
1.501180E-01 |
| Stage1-vs-Stage4 |
5.147000E-01 |
| Stage2-vs-Stage3 |
1.173950E-01 |
| Stage2-vs-Stage4 |
2.238800E-01 |
| Stage3-vs-Stage4 |
3.308400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.063700E-02 |
| Normal-vs-AfricanAmerican |
2.223600E-01 |
| Normal-vs-Asian |
2.610000E-02 |
| Caucasian-vs-AfricanAmerican |
3.842200E-03 |
| Caucasian-vs-Asian |
4.287000E-01 |
| AfricanAmerican-vs-Asian |
6.524200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.312100E-02 |
| Normal-vs-Female |
7.778900E-03 |
| Male-vs-Female |
9.927200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.169000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.85130000000578E-05 |
| Normal-vs-Age(61-80Yrs) |
1.886390E-01 |
| Normal-vs-Age(81-100Yrs) |
4.967600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.231400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.667800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.907600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.314400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.468200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.437400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.774400E-02 |
| Normal-vs-Grade 2 |
2.828800E-01 |
| Normal-vs-Grade 3 |
1.002470E-03 |
| Normal-vs-Grade 4 |
1.607640E-02 |
| Grade 1-vs-Grade 2 |
4.290800E-01 |
| Grade 1-vs-Grade 3 |
6.516200E-01 |
| Grade 1-vs-Grade 4 |
7.249000E-01 |
| Grade 2-vs-Grade 3 |
5.890200E-01 |
| Grade 2-vs-Grade 4 |
6.022600E-01 |
| Grade 3-vs-Grade 4 |
9.479800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.33260000004343E-06 |
| Normal-vs-ccB subtype |
4.60980000005495E-06 |
| ccA subtype-vs-ccB subtype |
7.245200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.100400E-01 |
| Normal-vs-N1 |
3.391400E-01 |
| N0-vs-N1 |
9.598800E-01 |
|
|
